PLoS computational biology · 2026
Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Quilty Billy J, Chapman Lloyd A C, Munday James D, Wong Kerry L M, Gimma Amy, Pickering Suzanne, Neil Stuart, Galao Rui Pedro, Edmunds W John, Jarvis Christopher I, Kucharski Adam J
Аннотация
SARS-CoV-2 transmission is highly overdispersed, with a minority of individuals responsible for the majority of transmission, though the drivers of this heterogeneity are unclear. Here, we assess the contribution of variation in viral load and daily contact rates to this heterogeneity by combining published viral load estimates and contact survey data in a mathematical model to estimate the secondary infection distribution. Using data from the BBC Pandemic and CoMix contact surveys, we estimate the secondary infection distribution throughout the pandemic in the UK in 2020, and the effectiveness of frequent and pre-event rapid testing for reducing superspreading events. We find that individual heterogeneity in contacts rather than individual heterogeneity in shedding is the main driver of observed heterogeneity in the secondary infection distribution. Our results suggest that everyone testing every 3 days would reduce the reproduction number below 1 and be equivalent in terms of impact on secondary infections to everyone testing only before events with a minimum event size of 10 for pre-pandemic contact levels. This work demonstrates the potential for using viral load and contact data to estimate heterogeneity in transmission and the effectiveness of rapid testing strategies for curbing transmission in future pandemics.